TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33288587 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 33288587 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33288587 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33289495 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 33289590 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study 33289918 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 33289920 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 33289956 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33290752 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33292000 — Surrogate Endpoint (SUR): Blood pressure
Study 33292297 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study 33292297 — Predictive Biomarker (PRD): PCLAF mRNA
Genes: PCLAF; KIAA0101; NS5ATP9; PAF; L5
Study 33292545 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 33292582 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33292612 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 33292612 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 33293291 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 33293316 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study 33293316 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 33293388 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33294861 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 33294861 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study 33294861 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33294918 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33295204 — Surrogate Endpoint (SUR): Blood pressure
Study 33296242 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 33296830 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 33296868 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33298619 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study 33298619 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33298619 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 33300144 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 33300372 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33300403 — Predictive Biomarker (PRD): PSMA7 mRNA
Genes: PSMA7; HSPC
Study 33301227 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 33301227 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 33301375 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33301375 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 33301375 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33301930 — Surrogate Endpoint (SUR): Bone mineral density
Study 33302031 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 33302225 — Predictive Biomarker (PRD): CAST mRNA
Genes: CAST
Study 33303023 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33303557 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33303745 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 33306031 — Surrogate Endpoint (SUR): Blood pressure
Study 33306036 — Predictive Biomarker (PRD): UBXN11 mRNA
Genes: UBXN11; SOC; UBXD5; PP2243
Study 33306036 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 33306187 — Surrogate Endpoint (SUR): Serum sodium
Study 33306598 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 33306625 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33307033 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 33307107 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study 33307107 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): miR-146a-5p
Genes: MIR146A
Study 33307107 — Predictive Biomarker (PRD): miR-21-5p
Genes: MIR21
Study 33307469 — Surrogate Endpoint (SUR): Bone mineral density
Study 33309581 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33310179 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33310179 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33310883 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33311588 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 33312759 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33312759 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33312766 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33314761 — Predictive Biomarker (PRD): UGT2B4 mRNA
Genes: UGT2B4; UGT2B11
Study 33314777 — Predictive Biomarker (PRD): LPIN2 mRNA
Genes: LPIN2; KIAA0249
Study 33314777 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 33314777 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33314777 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study 33314777 — Safety Biomarker (SAF): Interleukin 1
Study 33314777 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33315277 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 33315277 — Predictive Biomarker (PRD): EVL mRNA
Genes: EVL; RNB6
Study 33315694 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33316268 — Surrogate Endpoint (SUR): Serum uric acid
Study 33317530 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33317628 — Surrogate Endpoint (SUR): Blood pressure
Study 33317695 — Predictive Biomarker (PRD): TFEB mRNA
Genes: TFEB; BHLHE35
Study 33317858 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33317858 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 33319318 — Predictive Biomarker (PRD): TYMS
Genes: Tsase; TMS; HsT422
Study 33319471 — Surrogate Endpoint (SUR): Blood pressure
Study 33319498 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33320245 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 33320245 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33321118 — Surrogate Endpoint (SUR): Blood pressure
Study 33323025 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 33323401 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study 33323430 — Surrogate Endpoint (SUR): Bone mineral density
Study 33324397 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33324899 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study 33324905 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study 33324993 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33325055 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study 33325614 — Predictive Biomarker (PRD): CA3 mRNA
Genes: CA3
Study 33327047 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 33327268 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33327268 — Safety Biomarker (SAF): Platelet to lymphocyte
Study 33328058 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 33329326 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 33329400 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33330051 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33330959 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33331663 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33331662 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 33331662 — Surrogate Endpoint (SUR): Blood pressure
Study 33331670 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33331670 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33331996 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study 33331996 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 33332922 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 33332922 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 33332922 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33333899 — Predictive Biomarker (PRD): CENPJ mRNA
Genes: CENPJ; CPAP; LAP; LIP1
Study 33335322 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33336184 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 33336253 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33336372 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33336372 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 33336372 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study 33336372 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study 33336372 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 33336372 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study 33336372 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study 33336372 — Predictive Biomarker (PRD): Hepatitis A virus cellular receptor 2
Genes: HAVCR2; TIM3; TIMD3
Study 33336538 — Predictive Biomarker (PRD): DNAH5 mRNA
Genes: DNAH5; DNAHC5; HL1; KIAA1603
Study 33337584 — Predictive Biomarker (PRD): HRC mRNA
Genes: HRC; HCP
Study 33337811 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33340402 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 33341409 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 33341447 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 33341448 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33343722 — Surrogate Endpoint (SUR): Pathological complete response
Study 33344496 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study 33346365 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33346428 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 33346476 — Surrogate Endpoint (SUR): Serum creatinine
Study 33346510 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 33346510 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 33347495 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 33347715 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 33349123 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 33350030 — Surrogate Endpoint (SUR): Blood pressure
Study 33351103 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 33351137 — Predictive Biomarker (PRD): ENO1 mRNA
Genes: ENO1; ENO1L1; MBPB1; MPB1
Study 33351137 — Predictive Biomarker (PRD): Phospholipase A2 inhibitory protein
Genes: ANXA1; ANX1; LPC1
Study 33351205 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 33355229 — Monitoring Biomarker (MOI): C-C motif chemokine 4
Genes: CCL4; LAG1; MIP1B; SCYA4
Study 33355238 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33355238 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study 33356392 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33356398 — Surrogate Endpoint (SUR): Blood pressure
Study 33357452 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study 33358484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33358484 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 33358484 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 33358484 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 33358484 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33358484 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 33358484 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 33358484 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33358713 — Surrogate Endpoint (SUR): Blood pressure
Study 33358716 — Surrogate Endpoint (SUR): Blood pressure
Study 33359234 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33359404 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33359404 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 33359404 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33359404 — Predictive Biomarker (PRD): Microsatellite instability
Study 33362722 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 33362722 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33362722 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 33362722 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33363071 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 33364332 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 33364840 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33365012 — Surrogate Endpoint (SUR): Blood pressure
Study 33365012 — Surrogate Endpoint (SUR): Serum triglycerides
Study 33365012 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33368935 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33369212 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33369212 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33369570 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33369581 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33369581 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33370479 — Predictive Biomarker (PRD): PKLR mRNA
Genes: PKLR; PK1; PKL
Study 33370479 — Predictive Biomarker (PRD): Liver iron
Study 33371015 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 33371021 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study 33371033 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 33371033 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 33371044 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33371044 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33373868 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33373873 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33373873 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33374003 — Predictive Biomarker (PRD): ENO1 mRNA
Genes: ENO1; ENO1L1; MBPB1; MPB1
Study 33376109 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 33376169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33376181 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33376186 — Surrogate Endpoint (SUR): Serum testosterone
Study 33377328 — Surrogate Endpoint (SUR): Blood pressure
Study 33378424 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 33378424 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33378612 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33380512 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 33383315 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 33383315 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 33383315 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Lung surfactant protein D
Genes: SFTPD; COLEC7; PSPD; SFTP4
Study 33383350 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33383486 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 33383486 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 33383646 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33383646 — Predictive Biomarker (PRD): DLL4 mRNA
Genes: DLL4; UNQ1895/PRO4341
Study 33384402 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study 33387490 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 33389140 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33389140 — Safety Biomarker (SAF): BDNF
Study 33389355 — Surrogate Endpoint (SUR): Blood pressure
Study 33389388 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 33389388 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33389459 — Surrogate Endpoint (SUR): Blood pressure
Study 33391029 — Surrogate Endpoint (SUR): Blood pressure
Study 33392493 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 33392493 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33392493 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33392493 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 33392493 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33392770 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 33392801 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33392801 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study 33392801 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33394284 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 33394722 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 33394722 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 33395032 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 33398064 — Predictive Biomarker (PRD): AZIN2 mRNA
Genes: AZIN2; ADC; KIAA1945; ODCP
Study 33398536 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 33398536 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study 33398536 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 33398714 — Surrogate Endpoint (SUR): Serum creatinine
Study 33399383 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33399383 — Surrogate Endpoint (SUR): Blood pressure
Study 33400164 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33400438 — Predictive Biomarker (PRD): VILL mRNA
Genes: VILL
Study 33401364 — Surrogate Endpoint (SUR): Blood pressure
Study 33401363 — Predictive Biomarker (PRD): EBPL mRNA
Genes: EBPL; EBRP; ERP
Study 33402222 — Surrogate Endpoint (SUR): Blood pressure
Study 33402367 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33402367 — Predictive Biomarker (PRD): BAD mRNA
Genes: BAD; BBC6; BCL2L8
Study 33402692 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study 33404200 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33404519 — Monitoring Biomarker (MOI): HBV DNA
Study 33404789 — Surrogate Endpoint (SUR): Blood pressure
Study 33405090 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 33405090 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study 33405090 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 33405269 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33405269 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33405269 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 33405951 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study 33405951 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33406328 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33407104 — Safety Biomarker (SAF): Bacteroidetes phylum
Study 33407224 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33407577 — Predictive Biomarker (PRD): IFNAR1 mRNA
Genes: IFNAR1; IFNAR
Study 33407577 — Predictive Biomarker (PRD): GAS1 mRNA
Genes: GAS1
Study 33407577 — Predictive Biomarker (PRD): DUSP1 mRNA
Genes: DUSP1; CL100; MKP1; PTPN10; VH1
Study 33407577 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 33407671 — Predictive Biomarker (PRD): COL4A2 mRNA
Genes: COL4A2
Study 33407671 — Predictive Biomarker (PRD): COL26A1 mRNA
Genes: COL26A1; EMID2; EMU2
Study 33407671 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 33407671 — Predictive Biomarker (PRD): PROCR mRNA
Genes: PROCR; EPCR
Study 33407671 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 33407685 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33407685 — Safety Biomarker (SAF): BDNF
Study 33407727 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS